Starting from D2: 5 mg/day,QD. Symptomatic treatment:Subjects were treated corresponding treament plan in line with the release of a new coronavirus infection by the National Health and Medical Commis
Sponsors
Henan Provincial People's Hospital, The First Affiliated Hospital of HeNan University of CM
Conditions
Novel Coronavirus Pneumonia (COVID-19)
Early Phase 1
A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)
Active, not recruitingChiCTR2000030424
Start: 2020-03-02Updated: 2020-03-02
A single-center, single-arm clinical trial for azvudine in the treatment of novel coronavirus pneumonia (COVID-19)
RecruitingChiCTR2000030487
Start: 2020-03-04Updated: 2020-03-09